ERC Consolidator Grant for Laura De Laporte and the "HEARTBEAT" project
Growing human heart tissue in the laboratory - ERC Consolidator Grant for Laura De Laporte and the "HEARTBEAT" project
23.03.2022
Scientist Laura De Laporte (DWI – Leibniz Institute for Interactive Materials and RWTH Aachen University) has been awarded one of the most highly endowed research grants of the European Research Council (ERC): an ERC Consolidator Grant. This will fund the expansion of her research over five years.
In her project "HEARTBEAT", De Laporte and her team aim to grow vascularized, structured and beating human heart tissue in the laboratory. Her approach is to use interactive, micron-scale rod-shaped polymer networks - called microgels - to produce 3D constructs in high-throughput for growing human millimeter-sized heart tissues.
Laura De Laporte (right) inspects the microfluidic device together with her PhD student Yonca Kittel (left)
Products and exhibitors related to this topic
Exhibitors and products related to this topic can be found in the database of MEDICA 2021:
The Belgian scientist Prof. Dr.-Ing. Laura De Laporte (DWI – Leibniz Institute for Interactive Materials and RWTH Aachen University) has been awarded one of the most highly endowed research grants of the European Research Council (ERC): an ERC Consolidator Grant. This will fund the expansion of her research at the DWI in Aachen over five years with a budget of three million euros. In her project "HEARTBEAT", De Laporte and her team aim to grow vascularized, structured and beating human heart tissue in the laboratory. She wants to break with traditional methods of producing 3D biomaterials: Her approach is to use interactive, micron-scale rod-shaped polymer networks - called microgels - to produce 3D constructs in high-throughput for growing human millimeter-sized heart tissues. With a spatially controllable arrangement and movement of the microgels, she aims to build macroporous scaffolds with the ability to orient cells and enhance cell-cell interaction.
In the first step of the project, different types of microgels will be automatically assembled, magnetically aligned, and chemically interlinked in the presence of induced pluripotent stem cells to expand and organize the stem cells before differentiating them in cardiac cells. The 3D construct will be actuated with light to mimic the heartbeat and enhance the functionality of the growing tissue. In a second step, the aim is to grow blood vessels into the tissue to provide nutrients and oxygen to the growing mini-heart tissue. To achieve this, part of the microgels will be designed in such a way that they can be degraded on demand to ensure sufficient space for growing blood vessels.
"This project is a major step towards complex and interactive materials, as we know them from nature and thus also from the human body," explains De Laporte. Indeed, until now it has not been possible to create functional and personalized tissues including the biological structures and mature blood vessels. The main reason for this limitation is that current materials cannot replicate the complexity and dynamics of the natural cellular environment. "HEARTBEAT's unique bio-inspired 3D constructs – characterized by their macroporous and aligned structure – will resemble the complex biological architecture. At the same time, the actuation of the microgels mimics the heartbeat," describes De Laporte. The project aims to unravel how material properties, architectures, and the actuation of the microgels affect the formation and vascularization of human cardiac tissue, and how the construct needs to adapt to the growing tissue over time to provide the proper extracellular environment. Being able to grow functional human mini-tissue in a high-throughput, automated manner will provide a platform for drug testing and studying diseases, reducing the need for animal studies and better representing the human body, also with the possibility to grow patient-specific tissues.
MEDICA-tradefair.com; Source: DWI - Leibniz Institute for Interactive Materials